Myelodysplastic Syndromes (MDS)

TLK-199

Currently TLK-199: Currently TLK-199 is in Phase II of the Food and Drug Administration's (FDA's) clinical trial for the treatment of myelodsyplastic syndromes (MDS). is in Phase II of the

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.